Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Kava leaf contains kavalactones that modulate GABA neurotransmitter activity in the brain, producing anxiolytic and stress-reducing effects. The primary bioactive compounds include kavain, dihydrokavain, and methysticin, which interact with GABA-A receptors to promote relaxation.
Origin & History
Native to the South Pacific islands; thrives in volcanic soils and warm, humid climates Kava Leaf is harvested from plants found in regions spanning tropical rainforests to mountainous highlands. The leaves have been traditionally prepared as teas, extracts, and poultices by cultures throughout its native range, recognized for their concentrated bioactive compounds and therapeutic versatility.
Research Narrative (Provisional)
https://www.sciencedirect.com/science/article/pii/S1878535219301203
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
High in flavonoids, phenolic acids, mild kavalactones, potassium, magnesium, and dietary fiber. Provides anti-inflammatory, anxiolytic, and immune-boosting benefits. Detailed compositional analysis of Kava Leaf shows the presence of essential micronutrients including B-vitamins (thiamin, riboflavin, niacin), fat-soluble vitamins, and a mineral profile including potassium, phosphorus, and trace elements. The total dietary fiber fraction includes both soluble and insoluble components contributing to satiety and gut health.
Reported Mechanism (Provisional)
Kavalactones in kava leaf, particularly kavain and dihydrokavain, enhance GABA neurotransmitter binding to GABA-A receptors in the limbic system. These compounds also inhibit voltage-gated sodium channels and modulate dopamine reuptake. Additionally, kava's flavokavins demonstrate antioxidant activity through free radical scavenging mechanisms.
Clinical Narrative (Provisional)
Multiple randomized controlled trials involving 200-400 participants demonstrate kava's anxiolytic effects, with significant reductions in Hamilton Anxiety Rating Scale scores compared to placebo. A systematic review of 11 studies showed consistent stress reduction benefits with 120-300mg daily kavalactone intake. However, most studies are short-term (4-24 weeks), and evidence for cardiovascular and metabolic benefits remains limited to preliminary research.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.